PROCEPT BioRobotics Q4 revenue up 135% YoY to $23.8M; guides 2023 revenue ~$125M

PROCEPT BioRobotics Corp

2022-FY EPS reported -$1.96 revenue$75,014,000

Q4 2022 revenue $23.8M (+135% YoY); full year revenue $75.0M (+118% YoY).
U.S. handpiece/consumables revenue $10.4M (+202% YoY); system install base 167.
Net loss Q4 $28.2M vs $18.3M prior year; full year net loss $87.2M.
2023 guidance: revenue ~$125M (67% growth), gross margin ~53%, operating expense ~$163M.
Inventory write-offs of $0.7M in Q4 due to manufacturing yield issue, resolved in Q1 2023.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.